A Long-Term Study of JNT-517 in Participants With Phenylketonuria

Recruiting now · Phase 3

Conditions studied: Phenylketonuria (PKU)

In brief

The goal of this Phase 3, open-label study is to evaluate the long-term safety of JNT-517 in pediatric and adult participants with Phenylketonuria (PKU) after completion of either Study JNT517-101 (NCT05781399) or JNT517-201 (NCT06637514) as well as participants who have not participated in a prior JNT-517 study. In this trial, all participants will receive JNT-517 using age- and weight-banded dosing as outlined in the protocol, regardless of any dose received in a previous study.

Key facts

Study ID
NCT06628128
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
People needed
240
Starts
2025-08-11
Expected to finish
2028-02-01
Last updated by the study team
2026-05-01

Who can join

Age: 4 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.